Pharmaceutical policies: effects of financial incentives for prescribers (Q24243902)

2

0 references

Andrew D. Oxman

4

object named as

Andrew D Oxman

0 references

author name string

Heidrun Sturm

1

0 references

Morten Aaserud

3

0 references

Craig R Ramsay

5

0 references

Åsa Vernby

6

0 references

Jan Peter Kösters

Cochrane Database of Systematic Reviews

7

0 references

publication date

18 July 2007

0 references

published in

0 references

cites work

Effect of fundholding and indicative prescribing schemes on general practitioners' prescribing costs

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006731

Fundholders' prescribing costs: the first five years

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006731

The extent of the two tier service for fundholders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006731

How has fundholding in Northern Ireland affected prescribing patterns? A longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006731

Alterations in prescribing by general practitioner fundholders: an observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006731

Influences of practice characteristics on prescribing in fundholding and non-fundholding general practices: an observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006731

Budget holding in Calverton: one year on

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006731

The new NHS: the second year. Budget holding: here to stay?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006731

General practitioner fundholding and prescribing expenditure control. Evidence from a rural English health authority

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006731

A prescribing incentive scheme for non-fundholding general practices: an observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006731

Effect of NHS reforms on general practitioners' referral patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006731

Prospective study of trends in referral patterns in fundholding and non-fundholding practices in the Oxford region, 1990-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006731

Effects of the German 1993 health reform law upon primary care practitioners' individual performance: results from an empirical study in sentinel practices

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006731

General practice fundholding: observations on prescribing patterns and costs using the defined daily dose method

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006731

Fundholding in northern region: the first year

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006731

Health care expenditures after introduction of a gatekeeper and a global budget in a Swiss health insurance plan

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006731

Pharmaceutical policies: effects of reference pricing, other pricing, and purchasing policies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006731

Pharmaceutical policies: effects on rational drug use

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006731

Challenges to achieving value in drug spending in a decentralized country: the Spanish case.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006731

Drug cost containment policies in Italy: are they really effective in the long-run? The case of minimum reference price.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006731

Selection bias in GP fundholding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006731

Lessons from international experience in controlling pharmaceutical expenditure. II: Influencing doctors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006731

Priority setting in health policy in Sweden and a comparison with Norway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006731

Effects of financial incentives on medical practice: results from a systematic review of the literature and methodological issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006731

Utah's Prepaid Mental Health Plan: the first year

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006731

Penetrating the "black box": financial incentives for enhancing the quality of physician services

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006731

Interventions to improve antibiotic prescribing practices for hospital inpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006731

Variations in budgets of fundholding practices

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006731

Distribution of NHS funds between fundholding and non-fundholding practices

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006731

European healthcare policies for controlling drug expenditure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006731

The new pharmaceutical policy in Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006731

The drug budget silo mentality in Europe: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006731

The effect of fundholding on prescribing and referral costs: a review of the evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006731

Impact of payment method on behaviour of primary care physicians: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006731

Grading quality of evidence and strength of recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006731

An historical survey of UK government measures to control the NHS medicines expenditure from 1948 to 1996.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006731

Mass media interventions: effects on health services utilisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006731

Improving the quality of medical care: building bridges among professional pride, payer profit, and patient satisfaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006731

International comparisons of health care expenditures: what we know and what we do not know.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006731

Pharmaceutical expenditure in Spain: cost and control

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006731

Pricing and reimbursement of drugs in Sweden.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006731

What can PACT tell us about prescribing in general practice?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006731

Unified budgets for primary care groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006731

Dilemmas in regulation of the market for pharmaceuticals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006731

Quality-based payment: six case examples

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006731

Catching waves: the historical geography of the general practice fundholding initiative in England and Wales

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006731

Prescribing costs in dispensing practices

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006731

The pervasiveness of pharmaceutical expenditure inertia in the OECD countries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006731

Interrupted time series designs in health technology assessment: lessons from two systematic reviews of behavior change strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006731

Cross-national comparisons of health systems using OECD data, 1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006731

Prescribing incentive scheme for non-fundholding general practices. Reduction in prescribing cannot confidently be attributed to scheme

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006731

Paying for quality: providers' incentives for quality improvement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006731

Pay-for-performance and accountability: related themes in improving health care

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006731

Prescribing incentive scheme for non-fundholding general practices. Tailoring a scheme to individual practices is more effective

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006731

Clinical and economic consequences of a reimbursement restriction of nebulised respiratory therapy in adults: direct comparison of randomised and observational evaluations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006731

Using disease management and market reforms to address the adverse economic effects of drug budgets and price and reimbursement regulations in Germany.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006731

The effects of fundholding in general practice on prescribing habits three years after introduction of the scheme

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006731

Heart failure guidelines and prescribing in primary care across Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006731

Current prescribing in primary care in the UK. Effects of the indicative prescribing scheme and GP fundholding

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006731

Primary care reform: a three country comparison of 'budget holding'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006731

Evaluating general practice fundholding in the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006731

Do doctors respond to financial incentives? UK family doctors and the GP fundholder scheme

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006731

FROM CLINICAL RECOMMENDATIONS TO MANDATORY PRACTICE The Introduction of Regulatory Practice Guidelines in the French Healthcare System

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006731

Consequences of implementing a drug budget for office-based physicians in Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006731

Pay for Performance in Commercial HMOs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006731

An overview of pharmaceutical policy in four countries: France, Germany, the Netherlands and the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006731

7 January 2021

Effects of a monetary incentive on primary care prescribing in Ireland: changes in prescribing patterns in one health board 1990-1995

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006731

7 January 2021

The therapeutic gap--compliance with medication and guidelines

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006731

7 January 2021

General practice fundholders' prescribing savings in one region of the United Kingdom, 1991-1994

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006731

7 January 2021

Unintended effects of a cost-containment policy: results of a natural experiment in Germany

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006731

7 January 2021

Morbidity, deprivation and drug prescribing: factors affecting variations in prescribing between doctors’ practices

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006731

7 January 2021

Spending on pharmaceuticals in Italy: macro constraints with local autonomy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006731

7 January 2021

[Prescribing behavior of primary care physicians in diabetes therapy: effect of drug budgeting]

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006731

7 January 2021

Britain's National Health Service revisited

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006731

7 January 2021

Linking physicians' pay to the quality of care--a major experiment in the United kingdom

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006731

7 January 2021

GP fundholding and the costs of prescribing: further results

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006731

7 January 2021

Pharmaceutical cost growth under capitation: a case study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006731

7 January 2021

The UK indicative prescribing scheme: background and operation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006731

7 January 2021